Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helmut Hanenberg

Showing results (11-20 of 159) with videos related to

Pageof 16
Sort By:
Molecular Pharmacology|July 10, 2012
CYP4V2 in Bietti's crystalline dystrophy: ocular localization, metabolism of ω-3-polyunsaturated fatty acids, and functional deficit of the p.H331P variantMariko Nakano, Edward J Kelly, Constanze Wiek, et al.
Biological Chemistry|September 16, 2006
Impact of the arylhydrocarbon receptor on eugenol- and isoeugenol-induced cell cycle arrest in human immortalized keratinocytes (HaCaT)Michaela Kalmes, Andrea Neumeyer, Paola Rio, et al.
Frontiers in Immunology|February 15, 2021
HLA Class I Knockout Converts Allogeneic Primary NK Cells Into Suitable Effectors for "Off-the-Shelf" ImmunotherapyKeven Hoerster, Markus Uhrberg, Constanze Wiek, et al.
Human Mutation|January 12, 2005
Spectrum of sequence variations in the FANCA gene: an International Fanconi Anemia Registry (IFAR) studyOrna Levran, Raffaella Diotti, Kanan Pujara, et al.
Nature Genetics|January 18, 2011
Mutations of the SLX4 gene in Fanconi anemiaYonghwan Kim, Francis P Lach, Rohini Desetty, et al.
Journal of Medicinal Chemistry|April 18, 2020
Design and Characterization of the First Selective and Potent Mechanism-Based Inhibitor of Cytochrome P450 4Z1John P Kowalski, Matthew G McDonald, Robert D Pelletier, et al.
International Journal of Molecular Sciences|February 11, 2023
Spotlight on CYP4B1Annika Röder, Saskia Hüsken, Michael C Hutter, et al.
Pediatric Hematology and Oncology|February 23, 2016
Androgen therapy in Fanconi anemia: A retrospective analysis of 30 years in GermanyLaura Paustian, Mwe Mwe Chao, Helmut Hanenberg, et al.
European Journal of Medical Genetics|June 12, 2021
A homozygous nonsense mutation early in exon 5 of BRCA2 is associated with very severe Fanconi anemiaIvana Radulovic, Alma Kuechler, Michael M Schündeln, et al.
Blood|October 26, 2010
Patient-derived C-terminal mutation of FANCI causes protein mislocalization and reveals putative EDGE motif function in DNA repairLuca Colnaghi, Mathew J K Jones, Xiomaris M Cotto-Rios, et al.
Pageof 16

Showing results (11-20 of 159) with videos related to

Sort By:
Pageof 16
Molecular Pharmacology|July 10, 2012
CYP4V2 in Bietti's crystalline dystrophy: ocular localization, metabolism of ω-3-polyunsaturated fatty acids, and functional deficit of the p.H331P variantMariko Nakano, Edward J Kelly, Constanze Wiek, et al.
Biological Chemistry|September 16, 2006
Impact of the arylhydrocarbon receptor on eugenol- and isoeugenol-induced cell cycle arrest in human immortalized keratinocytes (HaCaT)Michaela Kalmes, Andrea Neumeyer, Paola Rio, et al.
Frontiers in Immunology|February 15, 2021
HLA Class I Knockout Converts Allogeneic Primary NK Cells Into Suitable Effectors for "Off-the-Shelf" ImmunotherapyKeven Hoerster, Markus Uhrberg, Constanze Wiek, et al.
Human Mutation|January 12, 2005
Spectrum of sequence variations in the FANCA gene: an International Fanconi Anemia Registry (IFAR) studyOrna Levran, Raffaella Diotti, Kanan Pujara, et al.
Nature Genetics|January 18, 2011
Mutations of the SLX4 gene in Fanconi anemiaYonghwan Kim, Francis P Lach, Rohini Desetty, et al.
Journal of Medicinal Chemistry|April 18, 2020
Design and Characterization of the First Selective and Potent Mechanism-Based Inhibitor of Cytochrome P450 4Z1John P Kowalski, Matthew G McDonald, Robert D Pelletier, et al.
International Journal of Molecular Sciences|February 11, 2023
Spotlight on CYP4B1Annika Röder, Saskia Hüsken, Michael C Hutter, et al.
Pediatric Hematology and Oncology|February 23, 2016
Androgen therapy in Fanconi anemia: A retrospective analysis of 30 years in GermanyLaura Paustian, Mwe Mwe Chao, Helmut Hanenberg, et al.
European Journal of Medical Genetics|June 12, 2021
A homozygous nonsense mutation early in exon 5 of BRCA2 is associated with very severe Fanconi anemiaIvana Radulovic, Alma Kuechler, Michael M Schündeln, et al.
Blood|October 26, 2010
Patient-derived C-terminal mutation of FANCI causes protein mislocalization and reveals putative EDGE motif function in DNA repairLuca Colnaghi, Mathew J K Jones, Xiomaris M Cotto-Rios, et al.
Pageof 16